Influence of non-gonadotrophic hormones on gonadal function

Molecular and Cellular Endocrinology

Volumn 161, Issue 1-2, 2000, Pages 37-42

  Pezzani, I ^a   Reis, F M ^a   Di Leonardo, C ^a   Luisi, S ^a   Santuz, M ^a   Driul, L ^a   Cobellis, L ^a   Petraglia, F ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Activin; Inhibin; Menstrual cycle; Ovarian granulosa cell tumours; PCO syndrome; Premature ovarian failure

Indexed keywords

ACTIVIN; ACTIVIN A; INHIBIN; INHIBIN A; INHIBIN B;

AGING; CONFERENCE PAPER; FEMALE; FEMALE GENITAL TRACT TUMOR; GONAD FUNCTION; GRANULOSA CELL TUMOR; HUMAN; MENSTRUAL CYCLE; MENSTRUATION DISORDER; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ACTIVINS; ANIMALS; FEMALE; FOLLICLE STIMULATING HORMONE; GENITAL NEOPLASMS, FEMALE; GROWTH SUBSTANCES; HUMANS; INFERTILITY, FEMALE; INHIBINS; OVARY; PREGNANCY;

EID: 0034732130     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00221-X     Document Type: Article

References (50)

1. Amsterdam A., Selvaraj N. Control of differerenciation, transformation and apoptosis in granulosa cells by oncogenes, oncoviruses and tumor suppressor genes. Endocrine Rev. 18:1997;435-461.
2. Anderson R.A., Groome N.P., Baird D.T. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin. Endocrinol. (Oxf). 48:1998;577-584.
3. Bilezikjian L.M., Vaughan J., Vale W.W. Characterization and the regulation of inhibin/activin subunit proteins of cultured rat anterior pituitary cells. Endocrinology. 133:1993;2545-2553.
4. Burger H.G., Cachir N., Robertson D.M. et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin. Endocrinol. (Oxf). 48:1998a;809-813.
5. Burger H.G., Baile A., Drummond A.E. et al. Inhibin and ovarian cancer. J. Reprod. Immunol. 39:1998b;77-87.
6. Cooke I., O'Brien M., Charnock F.M. et al. Inhibin as a marker for ovarian cancer. Br. J. Cancer. 71:1995;1046-1050.
7. Corrigan, A., Bilezikjian, L.M., Carroll, R.S., et al., 1991. Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology 128, 1682-1684.
8. Crofton P.M., Illingworth P.J., Groome N.P. et al. Changes in dimeric inhibin A and B during normal early puberty in boys and girls. Clin. Endocrinol. (Oxf). 46:1997;109-114.
9. Dalkin A.C., Haisenleder D.J., Yasin M., Gilrain J.T., Marshall J.C. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin. Endocrinology. 137:1996;548-554.
10. Danforth D.R., Arbogast L.K., Mroueh J. et al. Dimeric inhibin: a direct marker of ovarian aging. Fertil. Steril. 70:1998;119-123.
11. Di Simone N., Crwley W.F., Wang Q-F., Sluss P.M., Schneyer A.L. Characterization of inhibin/activin subunit, follistatin and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology. 137:1996;486-494.
12. Eramaa M., Hilden K., Tuuri T., Ritvos O. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells. Endocrinology. 136:1995;4382-4389.
13. Florio P., Lombardo M., Gallo R. et al. Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells. Placenta. 17(5-6):1996;307-311.
14. Florio P., Luisi S., Viganò P. et al. Healthy women and patients with endometriosis show high concentrations of inhibin A, inhibin B and activin A in peritoneal fluid throughout menstrual cycle. Hum. Reprod. 13:1998;2606-2611.
15. Groome N.P., Illingworth P.J., O'Brien M. et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 81:1996;1401-1405.
16. Healy D.L., Burger H.G. Inhibin: a serum marker for mucinous ovarian cancer. N. Engl. J. Med. 326:1992;466-471.
17. Healy D.L., Burger H.G., Mamers P. et al. Elevated serum inhibin concentrations in post-menopausal women with ovarian tumours. N. Engl. J. Med. 18:1993;1539-1542.
18. Hillier S.G., Yong E.L., Illingworth P.J., Baird D.T., Schwall R.H., Mason A.J. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol. Cell. Endocrinol. 75:1991;R1-R6.
19. Hofmann G.E., Danforth D.R., Seifer D.B. Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil. Steril. 69:1998;474-477.
20. Klein N.A, Illingworth P.J., Groome N.P., McNelly A.S., Bataglia D.E., Soules M.R. Decreased inhibin B secretion is associaated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J. Clin. Endocrinol. Metab. 81:1996;2742-2745.
21. Lambert Messerlian G.M., Steinhoff M., Zheng W. et al. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Gynecol. Oncol. 65:1997;512-516.
22. Li R., Phillips D.M., Mather J.P. Activin promotes ovarian follicle development in vitro. Endocrinology. 136:1995;849-856.
23. Lockwood G.M., Muttukrishna S., Groome N.P., Knight P.G., Ledger W.L. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clin. Endocrinol. (Oxf). 45(6):1996;741-748.
24. Lockwood G.M., Muttukrishna S., Groome N.P. et al. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. J. Clin. Endocrinol. Metab. 83:1998;1730-1735.
25. Luisi S., Battaglia C, Florio P. et al. Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, and maternal serum in early pregnancy. Placenta. 19:1998;435-438.
26. Magoffin D.A., Jakimiuk A.J. Inhibin A, inhibina B and activin A in the follicular fluid of regularly cycling women. Hum. Reprod. 12:1997;1714-1719.
27. Mather, J.P., Li, R.H., Phillips, D.J., Moore, A., 1997. Inhibin and activin as paracrine regulators of gonadal function: in vitro model systems. In: Aono, T., Sugino, H., Vale, W.W. (Eds.), Inhibin, Activin and Follistatin: Regulatory Functions in System and Cell Biology. Springer-Verlag, New York, p. 51-62.
28. Matzuk M.M., Finegold M.J., Su J.J. et al. inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 360:1992;313.
29. Muttukrishna S., Fowler P.A., George L. et al. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J. Clin. Endocrinol. Metab. 81:1996;3328-3334.
30. Petraglia F., Calza L., Garuti GC. et al. Presence and synthesis of inhibin subunits in human decidua. J. Clin. Endocrinol. Metab. 71:1990;487-492.
31. Petraglia F., Luisi S., Benedetto C. et al. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. J. Clin. Endocrinol. Metab. 82:1997;2991-2995.
32. Petraglia F., Hartmann B., Luisi S. et al. Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea. Fertil. Steril. 70:1998a;907-912.
33. Petraglia F., Luisi S., Pautier P. et al. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. J. Clin. Endocrinol. Metab. 83:1998b;1029-1032.
34. Petraglia F., Florio P., Luisi S. et al. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. J. Clin. Endocrinol. Metab. 83:1998c;1194-2000.
35. Petraglia F., Zanin E., Faletti A., Reis F.M. Inhibins:paracrine and endocrine effects in female reproductive function. Curr. Opin. Obstet. Gynecol. 11:1999;241-247.
36. Petraglia F. Inhibin, activin and follistatin in the human placenta- -a new family of regulatory proteins. Placenta. 18(1):1997;3-8.
37. Qu J., Thomas K. Inhibin and activin production in human placenta. Endocr. Rev. 16(4):1995;485-507.
38. Qu J., Ying S.Y., Thomas K. Inhibin production and secretion in human placental cells cultured in vitro. Obstet. Gynecol. 79:1992;705-712.
39. Reame N.E., Wyman T.L., Phillips D.J. et al. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J. Clin. Endocrinol. Metab. 83:1998;3302-3307.
40. Riley S.C., Wathen C.N., Chard T., Groome P.N., Wallace E.M. Inhibin in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum. Reprod. 11:1996;2772-2776.
41. Seifer D.B., Lambert Messerlian G., Hogan J.W., Gardiner A.C., Blazar A.S., Berk C.A. Day 3 serum inhibin B is predictive of assisted reproductive technologies outcome. Fertil. Steril. 67:1997;110-114.
42. Ueno N., Nishimatsu S., Murakami K. Activin as cell differentiation factor. Prog. Growth Factor Res. 2:1990;113-124.
43. Wallace E.M., Healy D.L. Inhibins and activins: roles in clinical practice. Br. J. Obstet. Gynaecol. 103:1996;945-956.
44. Wallace E.M., Riley S.C., Crossley J.A. et al. Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. J. Clin. Endocrinol. Metab. 82:1997;218-222.
45. Welt C., Martin K.A., Taylor A.E. et al. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J. Clin. Endocrinol. Metab. 82:1997;2645-2652.
46. Welt C., Lambert Messerlian G., Zheng W. et al. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. J. Clin. Endocrinol. Metab. 82:1997a;3720-3727.
47. Welt C.K., Martin K.A., Taylor A.E. et al. Frequency Modulation of Follicle-Stimulating Hormone (FSH) during the Luteal-Follicular transition: evidence for FSH Control of Inhibin B in normal Women. E. J. Clin. Endocrinol. Metab. 82:1997b;2645-2652.
48. Woodruff, T.K., Krummen, L., McCray, G., Mather, J.P., 1993. In situ ligand binding of recombinant human activin A and recombinant human inhibin A to the adult rat ovary. Endocrinology 133, 2998-3006.
49. Yamoto M., Imai M., Otani H., Nakano R. Serum levels of inhibin A and inhibin B in women with normal and abnormal luteal function. Obstet. Gynecol. 89:1997;776.
50. Zheng W., Luo M.P., Welt C. et al. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecol. Oncol. 69:1998;23-31.